MediPharm Labs Corp. (TSE:LABS – Get Free Report) dropped 6.7% on Thursday . The stock traded as low as C$0.07 and last traded at C$0.07. Approximately 107,441 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 376,219 shares. The stock had previously closed at C$0.08.
MediPharm Labs Price Performance
The stock has a 50 day moving average of C$0.07 and a 200-day moving average of C$0.07. The company has a current ratio of 3.11, a quick ratio of 3.10 and a debt-to-equity ratio of 5.90. The stock has a market capitalization of C$28.77 million, a P/E ratio of -1.75 and a beta of 0.88.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Read More
- Five stocks we like better than MediPharm Labs
- Canadian Penny Stocks: Can They Make You Rich?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Smart Picks: Discounted Stocks for Savvy Investors
- How to Find Undervalued Stocks
- NVIDIA Deal Ignites Aurora Stock’s Explosive Potential
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
